Related Experiment Video
Updated: Jul 6, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Changing HCV genotypes distribution in Poland--relation to source and time of infection
Slawomir Chlabicz1, Robert Flisiak, Oksana Kowalczuk
1Department of Family Medicine and Community Nursing, Medical University of Bialystok, Mieszka I 4 B, 15-054 Białystok, Poland. schlabicz@poczta.onet.pl
Insights
Hepatitis C virus (HCV) genotype 3 is increasingly prevalent in Poland, particularly among intravenous drug users (IVDU). Genotype 1b proportions have declined, indicating a shift in HCV epidemiology.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) genotype distribution impacts patient prognosis and treatment efficacy.
- Understanding regional HCV genotype patterns is crucial for public health strategies.
Purpose of the Study:
- To analyze the distribution of HCV genotypes in Poland.
- To correlate genotype prevalence with transmission routes and infection year.
Main Methods:
- Retrospective analysis of chronic liver disease patients in Bialystok, Poland.
- HCV genotyping using 5'UTR sequencing.
- Comparison with established genotype sequences.
Main Results:
- Genotype 1 was most frequent (57.5%), followed by genotype 3 (31.3%) and genotype 4 (8.4%).
- Genotype 1 dominated blood transfusion-associated infections (68.8%), while genotype 3 was more common in intravenous drug users (IVDU) (56.5%).
- A significant increase in genotype 3 infections was observed post-2000 (19.1% to 38.9%).
Conclusions:
- The proportion of HCV genotype 1b has decreased in Poland.
- HCV genotype 3a prevalence has risen, notably within the IVDU population.
- These shifts necessitate updated epidemiological surveillance and treatment guidelines.
Background:
Understanding the distribution of HCV genotypes has implications for prognosis and therapy of hepatitis C.
Objectives:
To describe the distribution of HCV genotypes in Poland in relation to route of transmission and year of infection.
Study Design:
Patients with chronic liver disease were evaluated at the Department of Infectious Diseases, Bialystok (Poland). HCV genotype was determined by means of 5'UTR sequencing and comparison with known sequences of particular genotypes.
Results:
The genotypes mostly frequently detected were genotype 1 (57.5%); genotype 3 (31.3%); and genotype 4 (8.4%). Genotype 1 constituted the majority of HCV infections caused by blood transfusion (68.8%) and only 34.8% of HCV infections in the intravenous drug use (IVDU) group (p<0.05). In contrast genotype 3 constituted the majority of HCV infections in the IVDU group (56.5%). We observed a significant increase in the proportion of genotype 3 infections detected after 2000--from 19.1% to 38.9%.
Conclusions:
The relative proportion of genotype 1b in Poland has decreased and that of genotype 3a has increased, especially among IVDU.
Related Concept Videos
Hepatitis
Cytomegalovirus Disease
Single Nucleotide Polymorphisms-SNPs
Genital Herpes
Viral Hepatitis I: Introduction
